Open AccessSafety and efficacy ofHansenula-derived PEGylated-interferon alpha-2a and ribavirin combination in chronic hepatitis C Egyptian children
Author(s) -
Suzan El Naghi
Publication year - 2014
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v20.i16.4681
Subject(s) - ribavirin , medicine , gastroenterology , pegylated interferon , regimen , adverse effect , hepatology , alpha interferon , hepatitis c , hepatitis c virus , interferon , immunology , virus
To investigate the safety and efficacy of a Hansenula-derived PEGylated (polyethylene glycol) interferon (IFN)-alpha-2a (Reiferon Retard) plus ribavirin customized regimen in treatment-naïve and previously treated (non-responders and relapsers) Egyptian children with chronic hepatitis C infection.